Thomas Steyer’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Thomas Steyer’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90,000	Closed	-$2.17M	–	199
2023 Q1	$2.17M	Buy	+90,000	New	+$1.13M	0.01%	136

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Thomas Steyer's PRVB Position: Q2 2023 in Review

Thomas Steyer sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 90,000 shares — an estimated $2.17M sold.

Thomas Steyer first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $2.17M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Thomas Steyer reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Thomas Steyer sold 90,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.17M.
Thomas Steyer first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Thomas Steyer's Provention Bio, Inc. Common Stock position peaked at $2.17M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.